Usefulness of a Pacing Guidewire to Facilitate Left Ventricular Lead Implantation in Cardiac Resynchronization Therapy

Background: Intraoperative measurements of left ventricular (LV) pacing and sensing values were assessed using a novel 0.014-inch guidewire (Visionwire^®, Biotronik GmbH, Berlin, Germany) enabling pacing and sensing at the distal tip before final LV lead implantation .
Methods: Twenty-two consecutive patients selected for cardiac resynchronization therapy were studied .
Results: Significant correlation was found between the LV pacing threshold as assessed by the Visionwire^® and values after final LV lead implantation (r = 0.92, P < 0.001). Correlation for LV sensing was also significant (r = 0.72, P < 0.001). No significant correlation was present with respect to phrenic nerve stimulation. However, no phrenic nerve stimulation at 10 V/0.5 ms using the Visionwire^® identified 88% of patients without phrenic nerve stimulation at 10 V/0.5 ms with subsequent LV lead measurements .
Conclusion: This technique may facilitate transvenous LV lead implantation by preventing implantation in a unsuitable target vessel with respect to pacing and sensing values or phrenic nerve stimulation, thereby reducing procedure and fluoroscopy time .     

Timing of the Left Ventricular Electrogram and Acute Hemodynamic Changes During Implant of Cardiac Resynchronization Therapy Devices

Study Objective: To examine the relationship between timing of the left ventricular (LV) electrogram (EGM) and its acute hemodynamic effect on instantaneous change in LV pressure (LVdP/dt_MAX).
Patients and Methods: In 30 patients (mean = age 67 ± 7.9 years) who underwent implant of cardiac resynchronization therapy systems, the right ventricular (RV) lead was implanted at the RV apex (n = 23) or RV septum (n = 7). The LV lead was placed in a posterior (n = 14) or posterolateral (n = 16) coronary sinus tributary. QRS duration, interval from Q wave to intrinsic deflection of the LV EGM (Q-LV), and interval between intrinsic deflection of RV EGM and LV EGM (RV-LV interval) were measured. The measurements were correlated with the hemodynamic effects of optimized biventricular (BiV) stimulation, using the Pearson correlation coefficient.
Results: The mean LVdP/dt_MAX at baseline was 734 ± 180 mmHg/s, and increased to 905 ± 165 mmHg/s during simultaneous BiV pacing, and to 933 ± 172 mmHg/s after V-V interval optimization. The Pearson correlation coefficient R between QRS duration, the Q-LV interval, and the RV-LV interval at the respective LVdP/dt_MAX was 0.291 (P = 0.66), 0.348 (P = 0.030), and 0.340 (P = 0.033).
Conclusions: Similar significant correlations were observed between the acute hemodynamic effect of optimized BiV stimulation and the Q-LV and the RV-LV intervals. However, individual measurements showed an 80-ms cut-off for the Q-LV interval, beyond which the increase in LVdP/dt_MAX was <10%._.     

Alternative Techniques for Left Ventricular Pacing in Cardiac Resynchronization Therapy

Cardiac resynchronization therapy (CRT) is an important treatment modality for a well‐defined subgroup of heart failure patients. Coronary sinus (CS) lead placement is the first‐line clinical approach but the insertion is unsuccessful in about 5–10% of the patients. In recent years, the number of CRT recipients and the considerable need for left ventricular (LV) lead revisions increased enormously. Numerous techniques and technologies have been specifically developed to provide alternatives for the CS LV pacing. Currently, the surgical access is most frequently used as a second choice by either minithoracotomy or especially the video‐assisted thoracoscopy. The transseptal or transapical endocardial LV lead implantations are being developed but there are no longer follow‐up data in larger patient cohorts. These new techniques should be reserved for patients failing conventional or surgical CRT implants. In the future, randomized studies are needed to asses the potential benefits of some alternative LV pacing techniques and other new technologies for LV lead placement are expected.     

Benefits of a Quadripolar Left Ventricular Lead in Patients Undergoing Cardiac Resynchronization Therapy with Underlying Myocardial Scar

We present a case of a 76‐year‐old man with ischemic cardiomyopathy. Cardiac magnetic resonance imaging demonstrated severe left ventricular (LV) impairment with possibility of scar formation. Cardiac resynchronization therapy was employed with the aid of a novel quadripolar LV lead. The quadripolar LV lead can be programmed for 10 different pacing configurations, allowing the electrophysiologist freedom to optimize the vector around scar and also avoid phrenic nerve stimulation without the requirement of LV lead repositioning. (PACE 2013; 36:e45–e47)     

Strength Duration Curve for Left Ventricular Epicardial Stimulation in Patients Undergoing Cardiac Resynchronization Therapy

Introduction: The strength duration curve has been studied for right ventricular endocardial stimulation. There are differences between left ventricular epicardial and right ventricular endocardial stimulation due to different electrophysiologic properties and different electrode-tissue interface. The strength duration curve for epicardial left ventricular stimulation has not been studied so far.
Methods: One hundred and three patients were studied. The strength duration curves were determined for left ventricular epicardial and right ventricular endocardial stimulation. The studied points were chronaxie, rheobase, and voltage threshold at 0.5 ms. Left ventricular leads Guidant 4512, 4513, 4537, 4538 (unipolar, area 3.5 mm²; Guidant Corp., St. Paul, MN, USA), Medtronic 4193 (unipolar, area 5.8 mm²; Medtronic Inc., Minneapolis, MN, USA), Guidant 4518, 4542, 4543 (bipolar, area 4 mm²), St. Jude Medical (bipolar, area 4.8 mm²; St. Jude Medical, St. Paul, MN, USA), and Medtronic 4194 (bipolar, area 5.8 mm²) were studied.
Results: The Guidant unipolar leads with a distal electrode area of 3.5 mm² had a lower chronaxie than the other studied leads. The left ventricular epicardial and right ventricular endocardial chronaxie for 15 patients with Medtronic left ventricular leads 4194 or 4193 (5.8 mm²) and right ventricular leads 6947 (5.7 mm²) were 0.52 ± 0.36 ms and 0.62 ± 0.46 ms (P > 0.05).
Conclusion: The left ventricular epicardial chronaxie depends on the lead. The left ventricular epicardial chronaxie is similar to the right ventricular endocardial chronaxie for leads with similar electrode stimulation area.     

Interlead Distance and Left Ventricular Lead Electrical Delay Predict Reverse Remodeling During Cardiac Resynchronization Therapy

Background: Both anatomic interlead separation and left ventricle lead electrical delay (LVLED) have been associated with outcomes following cardiac resynchronization therapy (CRT). However, the relationship between interlead distance and electrical delay in predicting CRT outcomes has not been defined. Methods: We studied 61 consecutive patients undergoing CRT for standard clinical indications. All patients underwent intraprocedural measurement of LVLED. Interlead distances in the horizontal (HD), vertical (VD), and direct (DD) dimensions were measured from postprocedure chest radiographs (CXR). Remodeling indices [percent change in left ventricle (LV) ejection fraction, end‐diastolic, end‐systolic dimensions] were assessed by transthoracic echocardiogram. Results: There was a positive correlation between corrected LVLED and HD on lateral CXR (r = 0.361, P = 0.004) and a negative correlation between LVLED and VD on posteroanterior (PA) CXR (r =?0.281, P = 0.028). To account for this inverse relationship, we developed a composite anatomic distance (defined as: lateral HD—PA VD), which correlated most closely with LVLED (r = 0.404, P = 0.001). Follow‐up was available for 48 patients. At a mean of 4.1 ± 3.2 months, patients with optimal values for both corrected LVLED (≥75%) and composite anatomic distance (≥15 cm) demonstrated greater reverse LV remodeling than patients with either one or neither of these optimized values. Conclusions: We identified a significant correlation between LV–right ventricular interlead distance and LVLED; additionally, both parameters act synergistically in predicting LV anatomic reverse remodeling. Efforts to optimize both interlead distance and electrical delay may improve CRT outcomes. (PACE 2010; 575–582)     

Left Ventricular Lead Fracture 6 Years after Implantation with a Retained Guidewire

We reported a case that left ventricular (LV) lead with retained guidewire was used 6 years ago, but the LV lead was broken during 6 years of follow‐up. Although the retained guidewire technique has already been abandoned, the long‐term safety of retained guidewire lead appears to be an even greater concern.     

Is the Left Ventricular Lateral Wall the Best Lead Implantation Site for Cardiac Resynchronization Therapy?

GASPARINI, M., et al .: Is the Left Ventricular Lateral Wall the Best Lead Implantation Site for Cardiac Resynchronization Therapy? Short-term hemodynamic studies consistently report greater effects of cardiac resynchronization therapy (CRT) in patients stimulated from a LV lateral coronary sinus tributary (CST) compared to a septal site. The aim of the study was to compare the long-term efficacy of CRT when performed from different LV stimulation sites. From October 1999 to April 2002, 158 patients (mean age 65 years, mean LVEF 0.29, mean QRS width 174 ms) underwent successful CRT, from the anterior (A) CST in 21 patients, the anterolateral (AL) CST in 37 patients, the lateral (L) CST in 57 patients, the posterolateral (PL) CST in 40 patients, and the middle cardiac vein (MCV) CST in 3 patients. NYHA functional class, 6-minute walk test, and echocardiographic measurements were examined at baseline, and at 3, 6, and 12 months. Comparisons were made among all pacing sites or between lateral and septal sites by grouping AL + L + PL CST as lateral site (134 patients, 85%) and A + MC CST as septal site (24 patients, 15%). In patients stimulated from lateral sites, LVEF increased from 0.30 to 0.39   (P < 0.0001)   , 6-minute walk test from 323 to 458 m   (P < 0.0001)   , and the proportion of NYHA Class III–IV patients decreased from 82% to 10%   (P < 0.0001)   . In patients stimulated from septal sites, LVEF increased from 0.28 to 0.41   (P < 0.0001)   , 6-minute walk test from 314 to 494 m   (P < 0.0001)   , and the proportion of NYHA Class III–IV patients decreased from 75% to 23%   (P < 0.0001)   . A significant improvement in cardiac function and increase in exercise capacity were observed over time regardless of the LV stimulation sites, either considered singly or grouped as lateral versus septal sites. (PACE 2003; 26[Pt. II]:162–168)     

Cardiac Resynchronization Therapy in Patients with Mildly Impaired Left Ventricular Function

Aims: We sought to determine the unknown effects of cardiac resynchronization therapy (CRT) in patients with a left ventricular ejection fraction (LVEF) >35%. Because of its technical limitations, echocardiography (Echo) may underestimate LVEF, compared with cardiovascular magnetic resonance (CMR).
Methods: Of 157 patients undergoing CRT (New York Heart Association [NYHA] functional class III or IV, QRS ≥ 120 ms), all of whom had a preimplant Echo-LVEF ≤35%, 130 had a CMR-LVEF ≤35% (Group A, 19.7 ± 7.0%[mean ± standard deviation]) and 27 had a CMR-LVEF >35% (Group B, 43.6 ± 7.7%). All patients underwent a CMR scan at baseline and a clinical evaluation, including a 6-minute walk test and a quality of life questionnaire, at baseline and after CRT.
Results: Both groups derived similar improvements in NYHA functional class (A =−1.3, B =−1.2, [mean]), quality of life scores (A =−21.6, B =−33.0; all P < 0.0001 for changes from baseline), and 6-minute walking distance (A = 64.5, B = 70.1 m; P < 0.001 and P < 0.0001, respectively). Symptomatic response rates (increase by ≥1 NYHA classes or 25% 6-minute walking distance) were 79% in group A and 92% in group B. Over a maximum follow-up period of 5.9 years for events, patients in group A were at a higher risk of death from any cause, hospitalization for major cardiovascular events (P = 0.0232), or cardiovascular death (P = 0.0411). There were borderline differences in the risk of death from any cause (P = 0.0664) and cardiovascular death or hospitalization for heart failure (P = 0.0526).
Conclusions: This observational study suggests that the benefits of CRT extend to patients with a LVEF > 35%.     

外科心脏再同步化治疗的超声心动图评价

目的 应用超声心动图来评价外科方法植入左室心外膜电极的心脏再同步化治疗(CRT)慢性心力衰竭的可行性和近期疗效.方法 接受外科CRT的慢性心力衰竭患者10例,用常规超声心动图及组织多普勒成像技术观察术前、术后左室收缩功能指标和心脏同步性参数的变化,并且在术中应用经食管超声心动图(TEE)指导左室心外膜电极位置的优选.结果 与术前比较,CRT术后的左室舒张末期内径(LVEDD)由(69.4±13.6) mm 降至 (60.0± 6.9 )mm(P<0.05),左室射血分数( LVEF )由(32.9±7.6)%升至(41.3±8.3) % (P<0.05 ) ,左室不同步指数12-Tp-SD由 (143.2±30.8) ms 降至(56.4±22.1)ms(P<0.05).结论 外科指导植入左室心外膜电极的CRT是安全的,有效的.传统超声心动图及组织同步显像技术能够指导左室心外膜电极放置于真正的靶位置,并评价其疗效.     

Long-Term Effectiveness of Dual Site Left Ventricular Cardiac Resynchronization Therapy in a Patient with Congestive Heart Failure

This article describes a case of cardiac resynchronization therapy (CRT) performed with dual site left ventricular pacing. The main clinical and functional long-term results are in agreement with the most recent data regarding traditional CRT. Furthermore, this innovative pacing modality allowed optimal inter- and intraventricular resynchronization. (PACE 2004; 27[Pt. I]:805–807)     

Complete Epicardial Resynchronization Device Implantation in a Patient Who Underwent a Replacement of Mitral and Tricuspid Valve

A 71‐year‐old woman with severe nonischemic dilated cardiomyopathy and low ejection fraction with severe mitral regurgitation and tricuspid regurgitation and pulmonary hypertension underwent multiple valve repairs and cardiac resynchronization therapy implantation with epicardial shock leads. (PACE 2013; 36:e56–e58)     

Adrenomedullin Plasma Levels Predict Left Ventricular Reverse Remodeling after Cardiac Resynchronization Therapy

Background: Increase in adrenomedullin (ADM) plasma levels in congestive heart failure (HF) patients is due to many cardiac and systemic factors, particularly to greater fluid retention and to activation of sympathetic nervous system. Aim of this study was to assess the role of plasma ADM levels in HF patients treated by cardiac resynchronization therapy (CRT). Methods: 50 patients, mean age 70 years, 34 male, New York Heart Association (NYHA) Class III–IV HF, left ventricular ejection fraction (LVEF) < 35%, underwent CRT. All patients were in sinus rhythm and with complete left bundle branch block (QRS duration 138 ± 6 msec). A complete echoDoppler exam, blood samples for brain natriuretic peptide (BNP), and ADM were obtained from 2 to 7 days before implantation. Results: At 16 ± 6 months follow‐up, ≥1 NYHA Class improvement was observed in 38 patients. However, a >10% reduction in end‐systolic dimensions (ESD) was reported in 21 patients (Group I): ?16.6 ± 1.8%; in the remaining 29 patients ESD change was almost negligible: ?2.0 ± 1.03% (Group II), P < 0.0001. The two groups were comparable for age, sex, cause of LV dysfunction, therapy, QRS duration at baseline, preimplantation ESD, LVEF%, and BNP. Significantly higher pre implantation ADM levels were present in Group I than in Group II (27.2 ± 1.8 pmol/l vs 17.9 ± 1.4, P = 0.0003). Conclusions: Significantly higher ADM levels indicate a subgroup of patients in whom reverse remodeling can be observed after CRT. Patients with lower ADM basal values before CRT could represent a group in whom the dysfunction is so advanced that no improvement can be expected. (PACE 2010; 865–872)     

Long‐Term Effects of Upgrading to Biventricular Pacing: Differences with Cardiac Resynchronization Therapy as Primary Indication

Background: Few studies have assessed the long‐term effects of cardiac resynchronization therapy (CRT) in patients with advanced heart failure (HF) and previously right ventricular apical pacing (RVAP). Aims: To assess the clinical and hemodynamic impact of upgrading to biventricular pacing in patients with severe HF and permanent RVAP in comparison with patients who had CRT implantation as initial therapy. Methods and Results: Thirty‐nine patients with RVAP, advanced HF (New York Heart Association [NYHA] III–IV), and severe depression of left ventricular ejection fraction (LVEF) were upgraded to biventricular pacing (group A). Mean duration of RVAP before upgrading was 41.8 ± 13.3 months. Clinical and echocardiographic results were compared to those obtained in a group of 43 patients with left bundle branch block and similar clinical characteristics undergoing “primary” CRT (group B). Mean follow‐up was 35 ± 10 months in patients of group A and 38 ± 12 months in group B. NYHA class significantly improved in groups A and B. LVEF increased from 0.23 ± 0.07 to 0.36 ± 0.09 (P < 0.001) and from 0.26 ± 0.02 to 0.34 ± 0.10 (P < 0.001), respectively. Hospitalizations were reduced by 81% and 77% (P < 0.001). Similar improvements in echocardiographic signs of ventricular desynchronization were also observed. Conclusion: Patients upgraded to CRT exhibit long‐term clinical and hemodynamic benefits that are similar to those observed in patients treated with CRT as initial strategy. (PACE 2010; 841–849)